No significant difference in OS between neoadjuvant and adjuvant immunotherapy. »
06/09/20

Anti-LGR5-ADC should be considered as therapeutic for high-grade ER− BC. »
06/10/20

Informed margin calculation and robust optimization of treatments. »
06/10/20

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy may offer survival benefit in select hepatocellular carcinomatosis. »
06/11/20

Novel interactions with DNA damage response proteins revealed. »
06/11/20

Significant heterogeneity in preferences for treatment attributes. »
06/11/20

17p13 deletions showed in clear cell RCC dependent prognostic role. »
06/13/20

Large decrease in outpatient visits and 46.8% decrease in surgical caseload. »
04/12/20

Reversible switching of ZEB2/ZEB1 ratio enhances melanoma metastatic dissemination. »
05/18/20

Greater protracted radiation exposure in low-dose range positively associated with lung cancer mortality. »
10/03/19